Download rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

page
1
page
2
page
3
page
4
page
5
Document related concepts
no text concepts found
Transcript 
From: rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and
Highly Infectious in Healthy Adult Volunteers
J Infect Dis. 2005;191(5):710-718. doi:10.1086/427780
J Infect Dis | © 2005 by the Infectious Diseases Society of America
From: rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and
Highly Infectious in Healthy Adult Volunteers
J Infect Dis. 2005;191(5):710-718. doi:10.1086/427780
J Infect Dis | © 2005 by the Infectious Diseases Society of America
From: rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and
Highly Infectious in Healthy Adult Volunteers
J Infect Dis. 2005;191(5):710-718. doi:10.1086/427780
J Infect Dis | © 2005 by the Infectious Diseases Society of America
From: rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and
Highly Infectious in Healthy Adult Volunteers
J Infect Dis. 2005;191(5):710-718. doi:10.1086/427780
J Infect Dis | © 2005 by the Infectious Diseases Society of America
From: rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and
Highly Infectious in Healthy Adult Volunteers
J Infect Dis. 2005;191(5):710-718. doi:10.1086/427780
J Infect Dis | © 2005 by the Infectious Diseases Society of America
Related documents